How Effective are Current Treatment Strategies, in Patients with Uterine Myomas?
نویسنده
چکیده
Copyright: © 2012 Androutsopoulos G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Uterine myomas are benign, hormone-sensitive, fibromuscular tumors that diagnosed in about 25%-40% of women during their reproductive age [1]. Uterine myomas may be asymptomatic or they can cause abnormal uterine bleeding, pelvic pain, pressure complaints, pregnancy-related complications and infertility [2].
منابع مشابه
Epidemiology of Uterine Myomas: A Review
s:1448:"Myomas are the most common benign tumors of the genital organs in women of childbearing age, causing significant morbidity and impairing their quality of life. In our investigation, we have reviewed the epidemiological data related to the development of myomas in order to homogenize the current data. Therefore, a MEDLINE and PubMed search, for the years 1990-2013, was conducted using a ...
متن کاملMRgFUS for Uterine Myomas: Safety, Effectiveness and Pathogenesis
Purpose Myomas are common benign tumors in woman. Patients prefer non-invasive treatment to preserve fertility and avoid surgery. In 2004 FDA approved MRgFUS for uterine myoma. The current study examined the safety and efficacy of MRgFUS for different myomas characteristics. Methods and Materials: A total of 925 patients, aged 20-55, with symptomatic myomas underwent MRgFUS (2006-2012). Prior t...
متن کاملUnmet therapeutic needs for uterine myomas.
Uterine myomas may develop in many women, but only become clinically significant in about one third of the affected population. Although uterine myomas are most often benign, they are associated with debilitating symptoms and commonly result in hysterectomy. Current treatments for uterine myomas include pharmacologic therapies, delivery of focused energy, alteration of uterine vascular supply, ...
متن کاملUterine Myomas: Recent Advances in their Treatment
Nowadays, uterine myomas represent a very common clinical entity. Approximately 20%-40% of the women in the reproductive age have uterine myomas [1,2]. However, in menopause there is a significant decrease in the incidence of uterine myomas [2,3]. A lot of patients with uterine myomas have no symptoms, because these tumors are usually asymptomatic [1]. Nevertheless, patients with uterine myomas...
متن کاملCurrent and emerging treatments for uterine myoma – an update
Uterine myomas, the most common benign, solid, pelvic tumors in women, occur in 20%-40% of women in their reproductive years and form the most common indication for hysterectomy. Various factors affect the choice of the best treatment modality for a given patient. Asymptomatic myomas may be managed by reassurance and careful follow up. Medical therapy should be tried as a first line of treatmen...
متن کامل